Tag: AKI
Roivios announces final enrolment for JuxtaFlow Renal Assist Device feasibility trial
Roivios has announced that they have enrolled the final patient for the BIPASS-AKI study for the JuxtaFlow renal assist device (RAD). The American Heart...
Statistical modelling promises better identification of drug-induced AKI
Drug-induced acute kidney injury (DI-AKI) is “challenging to distinguish” from other types of AKI even for “experienced nephrologists”, yet this adverse drug event (ADE)...
Renal Interventions’ top 10 stories of July
July was a month of acute kidney injury (AKI) updates and regulatory shifts, with empagliflozin winning European Medicines Agency approval and the US Food...
Mitochondrial transplantation found effective in reversing kidney damage
A new preclinical study, led by scientists at Wake Forest University School of Medicine (Winston-Salem, USA), shows that a new technology called mitochondrial transplantation holds...
Antihypertensive drugs found to heighten acute kidney injury risk
In a new retrospective cohort study, researchers at Beth Israel Deaconess Medical Center (BIDMC; Boston, USA) have examined the effects of the treatment of...
Biomarkers in urine and blood predict AKI progression to CKD, study...
In a new study looking at the long-term effects of hospitalised patients who have acute kidney injury (AKI), Johns Hopkins Medicine (Baltimore, USA) researchers...
Electronic alerts cut hospital stays for AKI patients as part of...
A new multicentre cohort study in Australia has been conducted to investigate the effectiveness of an electronic alert system for the development of acute...
Team-based coaching cuts acute kidney injury after heart procedures
Acute kidney injury (AKI) in patients who have undergone heart procedures can be reduced by implementing online team-based coaching more than by utilising alternative...
Darlington-based NHS trust dramatically reduces acute kidney injury risk with help...
Acute kidney injury (AKI) risks have been significantly reduced by healthcare professionals at County Durham and Darlington NHS Foundation Trust in the UK with...
Baxter gains FDA clearance for ST Set to treat acute kidney...
Baxter International has announced US Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set, intended for use in continuous renal replacement...